Skip to main content

Table 1 Different concentrations of ATRA and R428 used

From: AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia

Inhibitor Concentrations used (μM)
ATRA 0.41 0.82 1.62
R428 0.62 1.25 2.50